Amphetamines, Screen and Confirmation, Urine (Pain Management)
Also known as: Adderall®, Benzedrine®, Dexedrine®
Use
Detect and confirm the presence of amphetamine and/or methamphetamine.
Special Instructions
This assay is specifically designed for pain management and is not intended for workplace drug testing. It does not comply with state regulatory workplace testing programs.
Limitations
This assay is not intended for workplace drug testing programs and does not comply with related state regulatory requirements. The test measures specific compounds and will not detect other substances beyond amphetamines and methamphetamines. The detection capability is dependent on the sensitivity and specificity of the immunoassay and mass spectrometry methods used.
Methodology
Immunoassay (Initial testing by immunoassay (IA); confirmation of positives by mass spectrometry (MS))
Biomarkers
LOINC Codes
- 19261-7
- 3349-8
- 19344-1
- 16234-7
- 19555-2
- 16235-4
Result Turnaround Time
2-5 days
Related Documents
For more information, please review the documents below
Specimen
Urine
Volume
20 mL
Minimum Volume
Not provided
Container
Plastic urine container
Storage Instructions
Maintain specimen at room temperature. If arrival at lab will extend beyond seven days, refrigerate.